About Glukem
Glukem is a company based in Hyderabad (India) founded in 2014. It operates as a B2B. The company has 231 employees. Glukem operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Hyderabad, India
- Employees 231
- SectorsHealthcare
- Website glukembiocare.com
- Legal Name Glukem Biocare Private Limited
- Date of Incorporation 20 Oct, 2014
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹108 Cr
FY 2025 · +3% YoY
- Net Profit₹5.74 Cr
FY 2025 · 5% margin
- EBITDA₹10.89 Cr
FY 2025 · 10% margin
- Employee Count231
Associated legal entities of Glukem
Glukem operates through Glukem Biocare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Glukem Biocare Private Limited CIN U24232TG2014PTC096067 | Active | 20 Oct 2014 | Hyderabad, Telangana | ₹108 Cr | 231 | 6 | View details |
Board of directors of Glukem Biocare Private Limited (Glukem)
Glukem Biocare Private Limited is the primary company behind Glukem. The board of Glukem Biocare Private Limited currently have 6 directors; the longest-serving is Rakesh Chinnala, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rakesh Chinnala DIN 06794818 | Director | 20 Oct 2014 | 11 yrs 11 mo | Glukem Biocare Private Limited |
| Varun Vihar Madupaduga DIN 06988420 | Director | 20 Oct 2014 | 11 yrs 11 mo | Glukem Biocare Private Limited |
| Hazra Susanta Kumar DIN 02826580 | Director | 20 Oct 2014 | 11 yrs 11 mo | Glukem Biocare Private Limited |
| Ramanaiah Madupaduga DIN 03051922 | Director | 20 Oct 2014 | 11 yrs 11 mo | Glukem Biocare Private Limited |
| Rami Reddy Kolli DIN 07003923 | Director | 05 May 2015 | 11 yrs 5 mo | Glukem Biocare Private Limited |
| Omkar Reddy Bommu DIN 07040302 | Director | 05 May 2015 | 11 yrs 5 mo | Glukem Biocare Private Limited |
Financials of Glukem
Figures of Glukem Biocare Private Limited, the primary company behind Glukem, for FY 2025. Revenue was ₹108 Cr (+3% year on year). Net profit was ₹5.74 Cr (5% margin). EBITDA was ₹10.89 Cr (10% margin). Revenue has grown at a compounded annual rate of +12% over three years and +22% over five years.
- ₹108 CrRevenue · FY 2025 · +3% YoY
- ₹5.74 CrNet profit · 5% margin
- ₹10.89 CrEBITDA · 10% margin
- ₹99 LakhPaid-up capital
- 231Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Glukem Biocare Private Limited are on its company page.
Detailed financial statements for Glukem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Glukem
Glukem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| zelgen.com | 2009 | Suzhou, China | $61.92M | – | Company developing small molecules & eukaryotic cell based recombinant protein drugs | |
| capsugel.com | 1875 | Morristown, United States | – | – | Dosage forms are delivered for preclinical, clinical, and commercial supply. | |
| adarepharmasolutions.com | 2015 | Lawrence Township, United States | – | 217 | CDMO manufacturing solid drugs | |
| cpc.com | 1971 | Hauppauge, United States | – | 27 | Product development, manufacturing and packaging services | |
| lotuspharm.com | 1966 | Taipei, Taiwan | – | – | Contract manufacturing for oral solid formulations is offered. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | – | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | |
| vovantis.com | 2008 | Vadodara, India | – | 145 | Develops and manufactures novel effervescent drug delivery systems. |
Detailed competitors of Glukem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Glukem
10 companies that operate in the same segment as Glukem (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glukem
Glukem was founded in 2014.
Glukem is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Glukem has 231 employees.
The primary company behind Glukem, Glukem Biocare Private Limited, reported revenue of ₹108 Cr for FY 2025, up 3% year on year.
Glukem, established in 2014, excels in healthcare and pharmaceuticals, pharmaceutical manufacturing, drug production, and pellet and granule manufacturing. Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Glukem's top competitors include Inventia Healthcare, Zim Labs and Lotus.
Glukem operates through Glukem Biocare Private Limited.
The legal entities of Glukem currently have 6 directors, including Rakesh Chinnala, Varun Vihar Madupaduga, Rami Reddy Kolli and others.